Gammie AJ, Nichols JH, Egaddar O., Becker J., Dabla PK, Gouget B., Homšak E., Korita I., Kotani K., Saatçi E., Stankovic S., Uygun ZO, Abdel Wareth L., Mahato RV, Ganguly A., Ogong'a RO, Rytkönen J.
Inukai K., Miyashita K., Kotani K., Morimoto R., Kondo T., Hiraiwa H., Kazama S., Yoshida T., Yoshida S., Hattori T., Fukamachi K., Fukui N., Kato K., Yura Y., Ohashi K., Ouchi N., Murohara T., Okumura T., Takefuji M.
Miyoshi T., Shirai K., Horinaka S., Higaki J., Yamamura S., Saiki A., Takahashi M., Okura T., Kotani K., Kubozono T., Yoshioka R., Kihara H., Hasegawa K., Satoh-Asahara N., Yamaguchi O., Ito H.
Nichols JH, Assad RS, Becker J., Dabla PK, Gammie A., Gouget B., Heydlauf M., Homsak E., Korita I., Kotani K., Saatçi E., Stankovic S., Uygun ZO, AbdelWareth L.
Ann Clin Lab Sci 54(5) 710-712 2024年9月 査読有り最終著者責任著者
OBJECTIVE: Oxidative stress is considered to increase fracture risk, and lipid oxidation can adversely affect bone health. 4-hydroxynonenal (4-HNE) is a representative marker of lipid oxidation. METHODS: We investigated the association between 4-HNE and fracture risk in community-dwelling older subjects (n=78, mean age=78 years). Serum albumin, C-reactive protein, and 4-HNE values were examined with the Fracture Risk Assessment Tool (FRAX®). The FRAX® score of >15% was defined as a high fracture risk. RESULTS: There was a significantly higher 4-HNE value in the group of high fracture risk (n=38, median=12.4 ng/mL) than in the low-risk group (n=40, median=9.8 ng/mL; p=0.02). The correlation of FRAX® major osteoporosis (β=0.45) and FRAX® hip fracture (β=0.44) with 4-HNE was significant after adjustment for multiple variables. CONCLUSIONS: 4-HNE was suggested to be positively associated with fracture risk. This molecule may be a clinical candidate oxidative stress marker for fracture risk in the older population.